Geisinger announced Thursday that its board of directors appointed Dr. Jaewon Ryu, M.D. as interim president and CEO of Geisinger, effective Dec. 1.
Ryu, who has served as executive vice president and chief medical officer since September 2016, succeeds Dr. David T. Feinberg, M.D., MBA, who is leaving Geisinger on Jan. 3 to assume a leadership role at Google.
Feinberg will remain with Geisinger until that time to help facilitate a smooth transition.
Geisinger serves more than 1.5 million patients in New Jersey and Pennsylvania. AtlantiCare has been a member of Geisinger since Oct. 1, 2015.
Dr. Ryu has a deep understanding of the Geisinger organization and culture in addition to his management and physician experience, making him an ideal fit to lead the organization during this transition, said Don Stanziano, Geisinger’s chief marketing officer.
As chief medical officer, Dr. Ryu has overseen all aspects of patient care at Geisinger, working to improve patient access, expand value-based care model and foster more open communication to strengthen the relationships between Geisinger’s physicians and employees and the patients, families and communities.(tncms-asset)5a3ceb66-adf8-11e7-85ca-00163ec2aa77(/tncms-asset)
“He has been instrumental in leading many of our signature initiatives, including the redesign of Geisinger’s primary care model and the successful implementation of the Geisinger At Home program,” Stanziano said.
Board Chairman John C. Bravman, Ph.D., said the company is fortunate to have a proven leader in Ryu.
“Our board places a strong focus on developing talent throughout all levels of our organization, with the goal of fostering leaders who embody our core mission that has guided Geisinger for more than 100 years. Dr. Ryu is a great example of this, and I and the other members of our Board look forward to working with him,” said Bravman in a statement.
Ryu said when he joined Geisinger more than two years ago, he knew he was joining an organization with a longstanding national reputation for advancing medicine through innovation.
“I am honored to take on the role of interim CEO at this important time for Geisinger and the health care industry. Together with our outstanding leadership team and the commitment of our 32,000 employees, we’ll build on our legacy of putting patients at the center of all that we do,” said Ryu in a statement.